# Jürgen Kuball

Source: https://onco.cc/people/jurgen-kuball/  
OnCo record `jurgen-kuball` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies.

## Summary

Jürgen Kuball is Professor of Haematology at UMC Utrecht and a member of the Daily Board of its Strategic Program Cancer. He leads the haematology department and a translational research group developing gamma-delta T cell receptor-based cellular immunotherapies for haematological and solid cancers. His work spans allogeneic stem cell transplantation and engineered T cell products.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; haematology; immunotherapy
- Role: Daily Board member, Strategic Program Cancer
- Specialisms: Haematology; Cellular immunotherapy; Stem cell transplantation

## Sources

- Institution profile: https://research.umcutrecht.nl/strategic-programs/cancer/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Kuball+J%5BAuthor%5D

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- institutions: [UMC Utrecht Cancer Center](https://onco.cc/institutions/umc-utrecht/)
- journals: [Haematologica](https://onco.cc/journals/haematologica/)

---
JSON: https://onco.cc/api/v1/entities/jurgen-kuball.json